Efficacy of Sodium Hypochlorite in Eradicating Hepatitis C Virus (HCV)-RNA from the Peritoneal Effluent of PD Patients

Garcia-Valdecasas J. , Bernal C. , Garcia F. , Cerezo S. , Umana W.O. , von Albertini B. Epidemiology of hepatitis C virus infection in patients with renal disease. J Am Soc Nephrol 1994; 5: 186–92.

Bergman S. , Accortt N. , Turner A. , Glaze J. Hepatitis C infection is acquired pre-ESRD. Am J Kidney Dis 2005; 45: 684–9.

Moe S.M. , Pampalone A.J. , Ofner S. , Rosenman M. , Teal E. , Hui S.L. Association of hepatitis C virus infection with prevalence and development of kidney disease. Am J Kidney Dis 2008; 51: 885–92. Epub 28 Apr 2008 as doi:10.1053/j.ajkd.2008.03.009.

Selgas R. , Martinez-Zapico R. , Bajo M.A. , Romero J.R. , Munoz J. , Rinon C. Prevalence of hepatitis C antibodies (HCV) in a dialysis population at one center. Perit Dial Int 1992; 12: 28–30.

Lee G.S. , Roy D.K. , Fan F.Y. , Thanaletchumi K. , Woo K.T. Hepatitis C antibodies in patients on peritoneal dialysis: prevalence and risk factors. Perit Dial Int 1996; 16(Suppl 1): S424–8.

Huang C.C. , Wu M.S. , Lin D.Y. , Liaw Y.F. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1992; 12: 31–3.

Akpolat T ; Turkish Multicentre CAPD Study Group (TULIP). CAPD: a control strategy to prevent spread of HCV infection in end-stage renal disease. Perit Dial Int 2001; 21: 77–9.

Wang S.M. , Liu J.H. , Chou C.Y. , Huang C.C. , Shih C.M. , Chen W. Mortality in hepatitis C-positive patients treated with peritoneal dialysis. Perit Dial Int 2008; 28: 183–7.

Liou T.C. , Chang T.T. , Young K.C. , Lin X.Z. , Lin C.Y. , Wu H.L. Detection of HCV-RNA in saliva, urine, seminal fluid and ascites. J Med Virol 1992; 37: 197–202.

Gladziwa U. , Schlipkoter U. , Lorbeer B. , Cholmakow K. , Roggendorff M. , Sieberth H.G. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis—a multicenter study. Clin Nephrol 1993; 40: 46–52.

Krautzig S. , Tillmann H. , Wrenger E. , Manns M. , Koch K.M. , Brunkhorst R. Hepatitis-C virus (HCV) in peritoneal dialysis. Clin Nephrol 1994; 41: 120.

Castelnovo C. , Sampietro M. , De Vecchi A. , Corbetta N. , Cantu M. , Orlandi A. Diffusion of HCV through peritoneal membrane in HCV positive patients treated with continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1997; 12: 978–80.

Caramelo C. , Navas S. , Alberola M.L. , Bermejillo T. , Reyero A. , Carreño V. Evidence against transmission of hepatitis C virus through hemodialysis ultrafiltrate and peritoneal fluid. Nephron 1994; 66: 470–3.

Kirikçi G. , Karakoc A. Can hepatitis B and C infections contaminate because of drained dialysate in chronic PD treatment. EDTNA ERCA Journal 2003; 29.

Cusumano A. , Poratto F. , Pino N. , Fernández J. , Vilches A. Identification of hepatitis C virus RNA in peritoneal dialysis fluid of patients with viremia. Perit Dial Int 2005; 25: 478–82.

Kapadia F, Vlahov D, Des Jarlais DC, Strathdee SA, Ouellet L, Kerndt P, et al.; Second Collaborative Injection Drug User Study (CIDUS-II) Group. Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Epidemiology 2002; 13: 738–41.

Wright N.M. , Tompkins C.N. A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users. Harm Reduct J 2006; 3: 27.

Terpstra F.G. , van den Blink A.E. , Bos L.M. , Boots A.G. , Brinkhuis F.H. , Gijsen E. Resistance of surface-dried virus to common disinfection procedures. J Hosp Infect 2007; 66: 332–8. Epub 29 Jun 2007 as doi:10.1016/j.jhin.2007.05.005.

Breyer J.A. , Harbison M.A. Isolation of human immunodeficiency virus from peritoneal dialysate. Am J Kidney Dis 1993; 21: 23–5.

Scheel P.J. Jr. , Farzadegan H. , Ford D. , Malan M. , Watson A. Recovery of human immunodeficiency virus from peritoneal dialysis effluent. J Am Soc Nephrol 1995; 5: 1926–9.

Salo R.J. , Salo A.A. , Fahlberg W.J. , Ellzey J.T. Hepatitis B surface antigen (HBSAg) in peritoneal fluid of HBSAg carriers undergoing peritoneal dialysis. J Med Virol 1980; 6: 29–35.